9th World Congress on BA/BE Studies and Biowaivers
- Start Date:
- Monday, 17 July, 2017
- End Date:
- Wednesday, 19 July, 2017 12:00pm
- Oncology, Pediatrics, Emergency Medicine
Conference Series has been organizing International Conference on BA/BE Studies in consecutive years at America, over the last several years which met with great achievement in Business Conferencing and it has marked its Business very excited to expand Europe and Asia Pacific continents. Previous meetings were held in major cities like Baltimore, Chicago, Atlanta and Hyderabad. Its time to announce "9th World Congress on BA/BE Studies and Biowaivers" held July 17-19, 2017 at Melbourne, Australia.
The global generic drugs market 2016 report forecasts patent expiry of drugs worth $150 billion by 2020, which a key growth driver for top-selling drugs as well as new, inexpensive generic drugs.Patent expiry of a branded drug results in the introduction of inexpensive generic drugs in the market. Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market.The Australian pharmaceuticals industry comprises bio-medical research, biotechnology firms, originator and generic medicines companies and service-related segments including wholesaling and distribution.This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.
Everyone interested in the future of emerging - drugs majorly in the field drug discovery, design, drug development, pharmacokinetic research, clinical pharmacology and new therapeutic drugs on recent developments in the field of generic drug research, current challenges and possibilities in modeling a new drug involving bioavailability and bioequivalence research. Connect with our social network pages to get regular industry updates.
Sessions and discusiions invovles· Challenges in Drug Design and development· Pharmacokinetics and Pharmacodynamics in Drugs· Clinical Research Vs Clinical Trails· Study Designs· Factors affecting Bioavailability Studies· Need for conducting BA/BE Studies· Bioequivalence Assessment· Managing BA/BE Studies· Nutrient Bioavailability· Novel Drug Delivery Systems BA/BE approach· Current Isuues on BA/BE determination· Recent approaches to Biosimilars· BCS & IVIVC Based Biowaivers · Requirement of biowaivers
Conference organized by conference series LLC
Neurology is the study of injuries, disorders, diagnosis and treatment of thebrain, spine and nervoussystem including their coverings, blood vessels, and all effector tissues. There More than 600 known neurological disorders are there which affects our nervous system severely but still for most of the diseases treatment options are very limited and research is going on.
- JW Marriott Dubai